May cause acceleration of menstruation and menorrhagic extension of anovulatory menstrual cycle; thrombosis or thrombotic predisposition in patients concomitantly taking oral contraceptives; nausea, vomiting, hypernatremia, congestive heart failure and edema when administered at high doses; hypercalcemia and nephrolithiasis on long-term use.
View ADR Reporting Link